Dec 2017 With the DaVita Medical Group acquisition, OptumHealth deepens its presence in existing markets rather than adding new ones By Tory Wolff Payers , Providers OptumHealth and its proposed acquisition target DaVita Medical Group (… Read more
Dec 2017 United’s ambulatory delivery system OptumCare can reach 70% of the US population By Tory Wolff Payers , Providers Who will be the first to take integrated health care delivery national… Read more
Dec 2017 Gene therapy, headaches, and tattoos: an opinionated take on NEJM highlights for November 2017 By Marc Herant NEJM Two new therapies against a horrible congenital disease – but trouble … Read more
Oct 2017 Allegheny Health Network adds micro-hospitals to its ground game By Tory Wolff Providers UPMC’s recent spectacular deal-making careen through central Pennsylva… Read more
Oct 2017 Between the very common and the very rare – An opinionated take on NEJM highlights for October 2017 By Marc Herant NEJM Between the very common and the very rare – An opinionated take on NEJ… Read more
Oct 2017 Marrying into the right family pays off! Update on revenue cycle management joint venturing By Tory Wolff Providers Back in 2013, Dignity and Optum formed a joint venture for revenue cyc… Read more
Oct 2017 An opinionated take on NEJM highlights for September 2017 By Marc Herant NEJM A new drug to address hard-to-treat severe asthma In ~10% of people wi… Read more
Aug 2017 Price, costs, value, and rules: An opinionated take on NEJM highlights for August 2017 By Marc Herant NEJM At last, drug prices influence physician usage patterns Association of… Read more
Aug 2017 An opinionated take on NEJM highlights for July 2017 By Marc Herant NEJM Taking stock: two decades of progress in heart failure: Here comes a c… Read more
Jul 2017 UPMC’s race to the sea and the tentative steps towards Highmark-Geisinger alliance By Tory Wolff Payers , Providers On May 10, Highmark and Geisinger announced plans for a clinical joint… Read more
Jul 2017 June was negative-to-ambiguous: an opinionated take on NEJM highlights for June 2017 By Marc Herant NEJM Stent news First there was angioplasty, then bare stents, then drug-e… Read more
Jun 2017 An opinionated take on NEJM highlights for May 2017 By Marc Herant NEJM A hammer finds new nails (which happen to be eyeballs) The insulin gro… Read more
May 2017 April was a light month: an opinionated take on NEJM highlights for April 2017 By Marc Herant NEJM Calendaring care The length of our sidereal year is an accident – we h… Read more
Apr 2017 Urgent care gets drawn into system-level market share battles in the Big Apple By Tory Wolff Providers , Warburg Pincus, the new majority owners of CityMD, a 68 site urgent ca… Read more
Apr 2017 A population health approach to value-based drug pricing By Marc Herant Biopharma , Payers Working Paper Summary Drug companies are naturally incentivized… Read more
Mar 2017 Regeneration and mitigation: an opinionated take on NEJM highlights for March 2017 By Marc Herant NEJM Gene therapy for sickle cell disease Typical diseases targeted by gene… Read more
Mar 2017 It’s in the blood: an opinionated take on NEJM highlights for February 2017 By Marc Herant NEJM A knock at the door of a monster franchise Adalimumab (Humira, Abbvie)… Read more
Feb 2017 Keeping the pipes clean and the wires intact: an opinionated take on NEJM highlights for January 2017 By Marc Herant NEJM An innovative modality to suppress PCSK9 Antisense technology relies o… Read more
Jan 2017 Is Anthem drawing a line in the sand on drug pricing? By Jason Brauner Biopharma The public debate on drug pricing has sharpened markedly over the past… Read more
Jan 2017 A strong close to a banner year for progress against cancer: an opinionated take on NEJM highlights for December 2016 By Marc Herant NEJM Successful use of CAR-T therapy in a solid tumor Chimeric Antigen Rece… Read more
